Related Experiment Videos
[Use of statins following myocardial infarction before and after the 4S study]
E Krefting1, J B Hansen, A Nordøy
1Medisinsk avdeling Regionsykehuset i Tromsø.
Insights
Guidelines for statin treatment after the 4S study saw increased use. However, only half of eligible patients with high cholesterol received statins, indicating a need for better clinical practice adoption.
Area of Science:
- Cardiology
- Pharmacology
- Public Health
Context:
- Guidelines for statin therapy in coronary heart disease were established following the 4S study.
- Recommendations targeted patients with hypercholesterolemia, specific age criteria, and sufficient life expectancy.
Purpose:
- To evaluate the implementation of statin treatment guidelines in clinical practice.
- To assess changes in statin prescription rates before and after guideline dissemination.
Summary:
- A retrospective study analyzed two cohorts of myocardial infarction patients (1994 and 1996).
- Statin prescription rates increased from 4% in 1994 to 40% in 1996.
- In 1996, 50% of patients meeting cholesterol criteria (serum cholesterol > 5.5 mmol/l) received statins, often initiated during hospitalization.
Impact:
- The study highlights a significant increase in statin use post-guideline implementation.
- Further improvements in statin treatment require enhanced awareness and integration of research findings into clinical practice.
Abstract:
The 4S study was followed by guidelines for statin treatment of patients with manifest coronary heart disease recommending statins for patients with serum cholesterol above 5.5 mmol/l, age below 70 years, and more than three years life expectancy. The purpose of the present study was to investigate how these guidelines were implemented in clinical practice. A retrospective registration was conducted on two cohorts of patients; patients with myocardial infarction in 1994 (before 4S) (n = 101) and 1996 (n = 100). Risk factors for coronary diseases and the use of statins were registered from the patients records. No significant differences in risk factors between the two cohorts were observed. The proportion of patients given statins increased from 4% in 1994 to 40% in 1996, whereas 50% of patients with serum cholesterol above 5.5 mmol/l were given statins in 1996. Statin treatment was usually instituted during hospitalization. Awareness of actual prescription and handling of statin treatment, and adaption of knowledge from clinical studies to clinical practice is probably needed for further improvement of statin treatment.